No because it’s a private company of course but I do recall an announcement of distribution in Europe recently. No mention of the third party that former Bioamber licensed from.
It put to bed the creepy theory that a company with a license to a bankrupt company’s components could let go all their employees and still monetize those licenses (nothing to the third party) 3 years later.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.